Clinical trial
Biomarker Discovery for Predicting Autism Spectrum Disorder and Attention/Hyperactivity Disorders, and Identification of Environmental Factors Influencing Anxiety and Depression in Children, Adolescents, and Young Adults
NCT07570381 is registered in ClinicalTrials.gov with University of Exeter as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarker Discovery for Predicting Autism Spectrum Disorder and Attention/Hyperactivity Disorders, and Identification of Environmental Factors Influencing Anxiety and Depression in Children, Adolescents, and Young Adults
- Lead sponsor
- University of Exeter
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- August 1, 2026
- Completion date
- December 31, 2028
- Enrollment
- 800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adhd - attention deficit disorder with hyperactivity, autism spectrum disorder (asd), developmental coordination disorder (dcd)